'Spotted Bone Disease' | Benign Sclerosing Dysplasia | Multiple Enostoses | LEMD3 Mutation
- Spotted bone disease - numerous small, round, well-defined sclerotic foci (enostoses) clustered around joints (epiphyses and metaphyses), usually symmetrical and bilateral
- Benign and almost always asymptomatic - an incidental radiographic finding requiring no treatment
- Do-not-touch lesion - the most important job is to recognise it and avoid mistaking the spots for sclerotic (blastic) bone metastases
- Bone scan is typically cold - no increased radiotracer uptake, which separates it from metastases and active disease; a minority of atypical enostoses do take up tracer, so read it alongside radiographic stability
- LEMD3 (MAN1) germline mutation - autosomal dominant; when combined with skin connective-tissue naevi it is called Buschke-Ollendorff syndrome
- “Describe the spotted-bone pattern: multiple small round sclerotic foci concentrated in epiphyses and metaphyses, sparing the skull, ribs, vertebral bodies and mandible
- “State the single most important point: it is a do-not-touch, benign condition often confused with osteoblastic metastases - a cold bone scan plus serial stability resolves the dilemma
- “Know the family of sclerosing dysplasias: osteopoikilosis (round spots), osteopathia striata (linear striations), melorheostosis (dripping candle wax) - melorheostosis is LEMD3-linked only when it accompanies osteopoikilosis, and is mainly somatic MAP2K1
- “Name the named association: osteopoikilosis plus skin elastic-tissue naevi equals Buschke-Ollendorff syndrome
Overview and Epidemiology
Osteopoikilosis (Greek osteon, bone, and poikilos, spotted or mottled) is a benign, usually asymptomatic sclerosing bone dysplasia. It produces multiple small, round, well-defined sclerotic foci, each an enostosis or bone island, scattered through the skeleton with a striking periarticular concentration. Its examination importance is out of proportion to its rarity: it is a classic do-not-touch lesion and a notorious mimic of sclerotic bone metastases.
Who. Prevalence is estimated at around 1 in 50,000, with Buschke-Ollendorff syndrome quoted near 1 in 20,000. It can be found at any age, often in adolescence or adulthood, with a roughly equal sex distribution. Inheritance is autosomal dominant through a germline LEMD3 mutation, though sporadic cases occur.
Natural history. The spots are present from childhood and may increase in number with age. The course is benign and stable, the spots themselves do not undergo malignant transformation, and life expectancy is unaffected. The risk to the patient is iatrogenic over-investigation, not the disease.
Where. The distribution is characteristic enough to support the diagnosis on its own:
- Periarticular - clustered in the epiphyses and metaphyses around joints
- Appendicular - the hands, feet, pelvis and the ends of long bones are most heavily involved, including the proximal femur and the regions around the shoulder, knee and ankle
- Symmetrical - typically bilateral and roughly symmetrical
- Classically spared - the skull, ribs, clavicles, vertebral bodies and mandible are usually spared
This periarticular, symmetrical, small-tubular-bone pattern is the opposite of the axial-predominant, irregular pattern of sclerotic metastases, and recognising it is the heart of the exam answer.
Pathophysiology and Genetics
The gene. Hellemans and colleagues (2004) showed that heterozygous loss-of-function germline mutations in LEMD3, on chromosome 12, cause osteopoikilosis, Buschke-Ollendorff syndrome and some cases of melorheostosis. LEMD3 encodes MAN1, a protein of the inner nuclear membrane.
The mechanism. MAN1 normally antagonises TGF-beta and BMP signalling through its interaction with receptor-activated SMADs. Losing that brake leads to excess bone-forming signalling and the focal sclerotic noduli that define the disease.
The family. Osteopoikilosis belongs to a group of related sclerosing dysplasias that can overlap, and coexist in the same patient or family:
- Osteopoikilosis - multiple round sclerotic foci (spotted bones), LEMD3 germline
- Osteopathia striata - linear vertical striations, classically in the long-bone metaphyses and the ilium
- Melorheostosis - dripping candle wax cortical hyperostosis; predominantly somatic MAP2K1, but it can coexist with osteopoikilosis
- Mixed sclerosing bone dysplasia - features of more than one of these patterns in one skeleton
Inheritance and expressivity. Buschke-Ollendorff syndrome is osteopoikilosis with skin connective-tissue naevi, caused by the same gene. Penetrance of the LEMD3 variant is high, but expressivity varies within a family: some members show only the bone lesions, some only the skin naevi, and some both. Because you cannot predict which a carrier will show, a relative with normal skin may still have spotted bones (and vice versa), which is why you both examine the skin and image relatives.
Histology. Each focus has the features of a benign enostosis: dense, well-organised, mature compact lamellar bone within cancellous bone, in which normal Haversian systems may be present. Its spicules merge with the surrounding trabeculae, which is the radiographic rose-thorn or brush border. Studies of Buschke-Ollendorff syndrome describe the sclerotic noduli arising from modelling-based bone formation with a largely normal remodelling rate. The absence of woven bone, atypia and inflammation distinguishes it from malignancy, infection and active reactive bone.
Clinical Presentation
How it presents. Osteopoikilosis is usually silent, and the typical presentation is an unexpected radiographic finding:
- Incidental discovery, in most - spots seen on imaging done for trauma or another reason
- No symptoms, in most - no pain and no functional limitation
- Mild joint symptoms, in a minority - aching or effusion, often coincidental
- Skin lesions in Buschke-Ollendorff syndrome
- Family screening - spotted bones found when relatives of an affected patient are imaged
Examination. The joint and limb examination is typically normal, function is unaffected and there is no deformity, unlike melorheostosis. Pain is usually absent; if a patient has pain, consider another cause.
The skin. The connective-tissue naevi of Buschke-Ollendorff syndrome, classically termed dermatofibrosis lenticularis disseminata, are yellowish papules, nodules or plaques on the trunk, buttocks and limbs. They are usually asymptomatic, neither itchy nor painful, cosmetic only, and rarely need intervention. Histologically they contain excess broad elastic and/or collagen fibres, in two types that often coexist: elastin-rich (juvenile elastoma) and collagen-rich.
Why it matters. The clinical importance is almost entirely diagnostic. Recognising the benign pattern prevents unnecessary biopsy, cross-sectional imaging and oncological referral, and both patients and other clinicians need clear reassurance that the spots are not cancer. A patient with osteopoikilosis can still develop a malignancy, so persistent or atypical symptoms still deserve assessment; the spots simply should not be assumed to be metastases.
Imaging and Diagnosis
Radiographs. The diagnosis is usually made confidently on plain films. The hallmark is multiple small (typically 1 to 10 mm), round to ovoid, well-defined sclerotic foci in the epiphyses and metaphyses, and their bilateral symmetry is a strong clue to the benign nature. Individual foci may show a fine spiculated rose-thorn or brush border, and they are radiographically stable over years, unchanged on serial films, whereas metastases evolve.
CT. The foci are dense and of very high attenuation; enostoses typically have mean CT values well above 885 Hounsfield units. CT helps with an atypical or solitary lesion when bone island versus metastasis is in doubt.
Bone scan. Tc-99m bone scintigraphy, ideally with SPECT/CT, shows no increased uptake at the foci. Mature enostoses are metabolically inactive lamellar bone and do not accumulate diphosphonate, whereas osteoblastic metastases do, so a cold scan strongly supports benignity and argues against active metastases. It supports rather than proves: in the atypical-enostosis series in the evidence section, 4 of 11 bone islands did take up tracer. Increased uptake should make you doubt the diagnosis and look for metastasis or another active lesion, but a hot focus in a patient with known osteopoikilosis is not automatically a metastasis either.
Serial stability. An appearance unchanged over time is the strongest single discriminator, stronger than the bone scan. In the same series, enlargement was the commonest atypical feature (7 of 11).
MRI. MRI is increasingly the study a patient with cancer actually has. An osteopoikilotic focus is compact lamellar bone with no marrow, fat or free water, so it is uniformly low signal on T1, T2, proton-density and STIR, following cortical bone, with no surrounding marrow oedema and little or no contrast enhancement. A marrow-replacing sclerotic metastasis is typically low on T1 but often shows intermediate-to-high T2 signal, marrow oedema and enhancement. A focus that is dark on all sequences, oedema-free and non-enhancing is reassuringly a benign enostosis.
Most osteopoikilosis is benign and needs nothing further. Be cautious - and treat the lesion as suspicious - if any of these atypical features are present, because atypical enostoses can mimic blastic metastasis, low-grade central osteosarcoma or osteoid osteoma:
- Local pain or tenderness over a focus
- Increased uptake on bone scan
- Enlargement of a focus on serial imaging
- Unusually large size or aggressive-looking margins
- Atypically low CT attenuation for a bone island
SPOTSDiagnostic Features of Osteopoikilosis
Hook:SPOTS - think of the spotted appearance of the bones! It is the spotted-bone disease that must not be mistaken for cancer.
Management
The treatment is recognition. Typical osteopoikilosis has no medical or surgical treatment, and none is needed. The plan is to confirm the benign diagnosis radiographically, use a bone scan when metastases are in question, reassure the patient, document it clearly so it is not re-investigated, and avoid biopsy or excision.
The typical case. For the classic asymptomatic, incidental presentation, the small round symmetrical periarticular foci on plain films are enough. Explain that this is a benign, harmless, often inherited spotted-bone variant, and record the diagnosis prominently to prevent future unnecessary work-up. Look at the skin for connective-tissue naevi and ask about the family.
Diagnostic doubt. When metastases cannot be confidently excluded, for example in a patient with a known cancer:
- Tc-99m bone scan - a normal scan with no uptake strongly supports osteopoikilosis
- CT attenuation - very high Hounsfield values support a bone island
- Compare priors - stability over time supports benignity
- MDT input - discuss with radiology or musculoskeletal oncology if uncertainty persists
The atypical focus. A focus with pain, growth, uptake or large size is treated as a suspicious lesion, not assumed to be just an enostosis:
- Re-image with dedicated CT and/or MRI of the lesion in question
- Consider biopsy if imaging cannot exclude a low-grade osteosarcoma, osteoid osteoma or metastasis
- Refer to the musculoskeletal oncology or sarcoma service
Counselling. First-degree relatives may carry the same LEMD3 variant. In Buschke-Ollendorff syndrome, explain the autosomal-dominant inheritance and the benign nature of both the bone and the skin findings.
Complications and Pitfalls
The disease itself is benign. The complications in practice come from mismanagement and from coincidental disease:
- Misdiagnosis as metastases - unnecessary anxiety, imaging, biopsy and even oncological referral; the single most important pitfall
- Unnecessary biopsy of a do-not-touch lesion
- Missing a real lesion - anchoring on osteopoikilosis and dismissing a genuinely symptomatic or atypical focus that is actually a tumour
- Overlooking Buschke-Ollendorff syndrome - failing to examine the skin or take a family history
- Rare reported associations - occasional reports of dystocia, joint effusions and other findings, but these are not consistent features
Clinical Relevance and Exam Focus
What the examiner wants. The topic tests pattern recognition and clinical judgement rather than complex management. The examiner wants to see that you can recognise a benign do-not-touch lesion, construct a sensible differential for sclerotic bone lesions, use the right single test (bone scan) to argue against the dangerous mimic, and avoid harming the patient with unnecessary investigation. A confident, calm answer that prioritises not biopsying a benign lesion scores well.
- Pattern
- Small round symmetrical periarticular foci
- Bone Scan
- Normal (cold)
- Discriminator
- Benign, asymptomatic, stable; spares axial flat bones
- Pattern
- Irregular foci of variable size, axial predominance (spine, ribs, pelvis)
- Bone Scan
- Increased uptake (hot)
- Discriminator
- Symptomatic, known primary, evolves over time
- Pattern
- Sclerotic foci, may be axial
- Bone Scan
- Variable
- Discriminator
- Systemic features and other organ involvement
- Pattern
- Linear vertical striations in metaphyses
- Bone Scan
- Normal
- Discriminator
- Striped not spotted; same LEMD3 family
Gardner syndrome. Gardner syndrome, with multiple osteomas and bone islands and colonic polyposis, is a separate condition. It is a reminder that multiple bone islands occasionally signal a syndrome, so consider the whole patient.
Guidelines, Registries & Global Practice
Osteopoikilosis is too benign and too rare for any society (AAOS, BOA, EFORT, AO) to issue a dedicated guideline, and there is no disease registry. It instead appears in radiology and musculoskeletal-oncology teaching as one of the canonical do-not-touch lesions (alongside non-ossifying fibroma, fibrous cortical defect, bone island, and benign cortical irregularities). The globally consistent message is recognition, reassurance and avoidance of biopsy.
Global Epidemiology
- Prevalence: estimated around 1 in 50,000; Buschke-Ollendorff syndrome quoted near 1 in 20,000, with no geographic clustering
- Inheritance: autosomal dominant (germline LEMD3), reported worldwide across populations
- Detection: overwhelmingly incidental, on imaging performed for unrelated reasons
Reference Sources Instead of Guidelines
- Type
- Molecular
- Contribution
- Established autosomal-dominant LEMD3/MAN1 basis and the link to Buschke-Ollendorff and melorheostosis
- Type
- Educational consensus
- Contribution
- Places osteopoikilosis among benign lesions that should not be biopsied
- Type
- Case series
- Contribution
- Defines imaging thresholds (CT attenuation, bone scan) that separate benign from suspicious foci
Practice Variation by Resource Setting
- Diagnosis
- Plain films, with CT attenuation and SPECT/CT or bone scan when metastases must be excluded; genetic testing available for syndromic cases
- Management
- Recognition and reassurance; no treatment; document to prevent re-investigation
- Diagnosis
- Diagnosis on plain radiographs alone (symmetrical periarticular spotted pattern); advanced imaging and genetics often unavailable
- Management
- Conservative reassurance; reserve referral for genuinely atypical or symptomatic foci
Pragmatic Global Principles
- Diagnosis is usually radiographic; the symmetrical, periarticular, small-tubular-bone pattern is the key
- Use a bone scan (cold foci) as the simplest discriminator from blastic metastases when there is doubt
- Do not biopsy a typical lesion; reserve biopsy for atypical foci that could be malignant
- Examine the skin and ask about family history to identify Buschke-Ollendorff syndrome
- Document the diagnosis clearly so the patient is not repeatedly investigated for cancer
Related pages: Sclerosing Bone Dysplasias is the parent framework and the place to see osteopoikilosis beside osteopathia striata, osteopetrosis and the mixed forms. Bone Island (Enostosis) is the same lesion in its solitary form and carries the CT attenuation threshold this diagnosis leans on - a mean above 885 Hounsfield units - together with the rose-thorn margin. Melorheostosis is the sibling that must be read with the genetics kept straight: it belongs to the LEMD3 family only when it arises on a background of osteopoikilosis, because most sporadic melorheostosis is caused by somatic MAP2K1 mutation instead. Metastatic Bone Disease is the whole reason this topic matters, and the discriminators are pattern (uniform, small, symmetric, periarticular against irregular, variable, axial), activity on bone scan, and above all stability over time. Osteoid Osteoma and Osteoblastoma are the benign active lesions an atypical, painful, tracer-avid enostosis can imitate, and Osteosarcoma - specifically its low-grade central form - is the malignant one. Describing a Bone Tumour Radiograph supplies the vocabulary for saying why these foci are benign, and Systematic Approach to Tumour Imaging the sequence for investigating one that is not. Paget's Disease of Bone and Fibrous Dysplasia complete the differential for sclerotic or mixed-density lesions found incidentally in an adult skeleton.
Viva Practice Scenarios
Practise clinical reasoning and management decisions out loud
“A 45-year-old man has a chest and abdomen CT for abdominal pain. The report flags 'multiple sclerotic foci throughout the pelvis and proximal femora - query metastases'. He is otherwise well. How would you assess this?”
“You are shown a radiograph of both hands demonstrating numerous small round sclerotic foci in the carpals and phalanges. What is the diagnosis, and what is the underlying genetic basis?”
“A patient with known prostate cancer is found to have multiple sclerotic bony foci. The oncologist asks whether these represent metastatic disease. How would you help resolve this?”
Definition and Key Facts
Genetics
Radiographic Pattern
Confirming Benignity
Differential Diagnosis
Management
Exam Pearls
Evidence and Key Studies
Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis
- Heterozygous loss-of-function germline mutations in LEMD3 (MAN1) cause osteopoikilosis and Buschke-Ollendorff syndrome
- Established the autosomal-dominant genetic basis of the spotted-bone phenotype on chromosome 12
- MAN1 antagonises BMP and TGF-beta signalling by interacting with receptor-activated SMADs - losing this brake favours bone formation
- Some patients with melorheostosis also carried LEMD3 mutations, linking the three sclerosing dysplasias on one pathway
Melorheostosis and osteopoikilosis: a review of clinical features and pathogenesis
- Osteopoikilosis is caused by germline LEMD3 mutations that perturb TGF-beta / BMP signalling via the nuclear-membrane protein MAN1
- It can co-occur with melorheostosis, supporting a shared signalling pathway across the sclerosing dysplasias
- There is substantial radiographic overlap within mixed sclerosing bone dysplasia
- Distinguishing benign sclerosing dysplasia from malignancy remains the central clinical challenge
Benign incidental findings of osteopoikilosis on Tc-99m MDP bone SPECT/CT: a case report and literature review
- Multiple punctate sclerotic foci on radiograph showed no abnormal uptake on Tc-99m MDP bone scan with SPECT/CT
- The normal scan made bone metastasis unlikely and confirmed osteopoikilosis
- Symptoms (in this patient, hip pain) settled with conservative measures, underscoring the benign nature
- SPECT/CT can establish the diagnosis in a single step by combining the cold foci with their CT density
Atypical enostoses - series of ten cases and literature review
- Typical bone islands are painless, show a rose-thorn radiating margin, mean CT attenuation above 885 Hounsfield units, and no uptake on bone scan
- Atypical enostoses (pain, enlargement, increased uptake, aberrant attenuation) can mimic osteoblastic metastasis, low-grade central osteosarcoma, osteoid osteoma and osteoblastoma
- Some cases occurred in the setting of osteopoikilosis, and one in Gardner syndrome
- Atypical features should trigger further imaging and consideration of biopsy
References
- Hellemans J, Preobrazhenska O, Willaert A, et al. Loss-of-function mutations in LEMD3 result in osteopoikilosis, Buschke-Ollendorff syndrome and melorheostosis. Nature Genetics. 2004;36(11):1213-1218. PMID: 15489854.
- Wordsworth P, Chan M. Melorheostosis and osteopoikilosis: a review of clinical features and pathogenesis. Calcified Tissue International. 2019;104(5):530-543. PMID: 30989250.
- Tsai SY, Wang SY, Shiau YC, Wu YW. Benign incidental findings of osteopoikilosis on Tc-99m MDP bone SPECT/CT: a case report and literature review. Medicine (Baltimore). 2016;95(23):e3868. PMID: 27281099.
- Bedard T, Mohammed M, Serinelli S, Damron TA. Atypical enostoses - series of ten cases and literature review. Medicina (Kaunas). 2020;56(10):534. PMID: 33065973.
- Hassikou H, Tabache F, Safi S, Baaj M, Hadri L. Buschke-Ollendorff syndrome. Joint Bone Spine. 2008;75(2):212-214. PMID: 18313966.
- Frost M, Rahbek ET, Ejersted C, et al. Modeling-based bone formation transforms trabeculae to cortical bone in the sclerotic areas in Buschke-Ollendorff syndrome. Bone. 2020;135:115313. PMID: 32151766.
Evidence retrieved from PubMed. DOIs: 10.1038/ng1453; 10.1007/s00223-019-00543-y; 10.1097/MD.0000000000003868; 10.3390/medicina56100534; 10.1016/j.jbspin.2007.04.027; 10.1016/j.bone.2020.115313.